NCT05971017

Brief Summary

The aim of the project is to study the influence of biostimulate crops on a healthy population in order to assess influence on hematological parameters and specific metabolism (glucose, lipid, iron, bone) and gut and lipid hormones. Secondary outcome will be to find out micronutrient presence in urine and serum. The use of biostimulation in modern agriculture has rapidly expanded in recent years, owing to their beneficial effects on crop yield and product quality, which have come under the scope of intensive research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

2 months

First QC Date

July 12, 2023

Last Update Submit

July 30, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • hepatic metabolism

    AST (aspartate transaminase) and ALT (Alanine aminotransferase) will be measured in serum will be assessed at baseline and after 15 days

    15 days

  • iron metabolism

    ferritin, transferrin, % saturation of transferrin will be measured in serum will be assessed at baseline and after 15 days

    15 days

  • Lipid metabolism

    triglycerides, HDL, LDL, cholesterol will be measured in serum will be assessed at baseline and after 15 days

    15 days

  • Glucose metabolism

    insulin, glucose will be measured in serum will be assessed at baseline and after 15 days

    15 days

  • Gastrointestinal peptides and lipid hormones

    Plasma concentrations of Gastrointestinal peptides (GLP-1, GLP-2, GIP, PYY, Ghrelin) and lipid hormones (leptin, resistin, adiponectin) will be assessed at baseline and after and after 15 days.

    15 days

  • Serum bone remodelling markers

    PTH, calcitonin, Vitamin D, Calcium, Phosphate, Potassium will be assessed at baseline and after and after 15 days.

    15 days

  • Serum bone matabolism markers

    bone resorption CTX and bone formation osteocalcin will be assessed at baseline and after 15 days.

    15 days

  • body mass index (BMI)

    Weight (Kg) Height (m) BMI (kg/m2)

    15 days

Secondary Outcomes (1)

  • body composition

    15 days

Study Arms (2)

Control group

PLACEBO COMPARATOR

To the control group was assigned lettuce without any biostimulation but with the same characteristic of biostimulated lettuce (soil, water, harvesting time)

Dietary Supplement: Control Group

Biostimulated Group

EXPERIMENTAL

experimental: Biostimulated group: To the intervention group was assigned the biostimulated lettuce.

Dietary Supplement: Biostimulated group

Interventions

Control GroupDIETARY_SUPPLEMENT

Lettuce without any biostimulation was assigned to each participant belonging to the control group which ate 100gr every day for 15 days

Also known as: Placebo Comparator
Control group
Biostimulated groupDIETARY_SUPPLEMENT

Intervention biostimulated group 100gr of biostimulated lettuce were assigned to each participant belonging to the intervention group which ate 100 grams every day for a total of 15 days

Also known as: Intervention group
Biostimulated Group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Caucasian
  • age: 18-90 years
  • currently injury free
  • Body mass index between 18.5 and 28 kg/m2

You may not qualify if:

  • bone fracture within the previous year
  • use of medication or suffering from any condition known to affect bone, lipid, glucose, iron metabolism
  • pregnancy
  • breastfeeding
  • current smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NABbio, STEBICEF department

Palermo, 90128, Italy

Location

MeSH Terms

Conditions

MalnutritionBone ResorptionGlucose Metabolism DisordersLipid Metabolism DisordersFatty Liver

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Sara Baldassano Professor, PhD

    University of Palermo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Two groups that consumed lettuce. No differences in shape, size, colours of lettuce
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: control group, biostimulated group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PROFESSOR

Study Record Dates

First Submitted

July 12, 2023

First Posted

August 2, 2023

Study Start

March 1, 2023

Primary Completion

May 2, 2023

Study Completion

July 9, 2023

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Because is forbidden by the Italian Low

Locations